Iron induces Bcl-2 expression in human dermal microvascular endothelial cells
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 34 (3) , 221-235
- https://doi.org/10.1080/10715760100300211
Abstract
Iron is suspected to be involved in the induction and/or progression of various human tumors. The present study was designed to investigate the effects of iron on endothelial cells, keeping in mind that the homeostasis of microvessels plays a critical role in neo-angiogenesis. Applying a model of human dermal microvascular endothelial cell terminal differentiation and death induced by serum deprivation, we found that iron salts (iron chloride and ferric nitrilotriacetate) provided a survival advantage to endothelial cells. Using immunohistochemistry and Western Blot analysis, we found that the extended cellular life span induced by iron was paralleled by an increase of Bcl-2 protein expression. Taken together, these observations suggest that iron may give a survival advantage to endothelial cells and represent a novel mechanism through which iron may contribute to tumorigenesis.Keywords
This publication has 27 references indexed in Scilit:
- Overexpression of Bcl-2 in Kaposi's Sarcoma-Derived CellsJournal of Investigative Dermatology, 1998
- Energy Metabolism during ApoptosisPublished by Elsevier ,1997
- Suppression of Bcl‐2 gene expression by sphingosine in the apoptosis of human leukemic HL‐60 cells during phorbol ester‐induced terminal differentiationFEBS Letters, 1996
- Overexpression of the Bcl-2 Protein Increases the Half-life of p21BaxJournal of Biological Chemistry, 1995
- bcl-2 Gene Prevents Apoptosis of Basic Fibroblast Growth Factor-Deprived Murine Aortic Endothelial CellsExperimental Cell Research, 1994
- Commitment to Cell Death Is Signaled by the Appearance of a Terminin Protein of 30 kDaExperimental Cell Research, 1994
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Iron in CancerPathobiology, 1992
- Ribonucleotide Reductase—a Radical EnzymeScience, 1983